Fagron NV (FAGR.BR)
- Previous Close
17.64 - Open
17.64 - Bid --
- Ask --
- Day's Range
17.64 - 17.82 - 52 Week Range
14.64 - 18.40 - Volume
25,191 - Avg. Volume
57,778 - Market Cap (intraday)
1.296B - Beta (5Y Monthly) 0.28
- PE Ratio (TTM)
18.31 - EPS (TTM)
0.97 - Earnings Date Apr 11, 2024 - Apr 15, 2024
- Forward Dividend & Yield 0.25 (1.41%)
- Ex-Dividend Date May 15, 2023
- 1y Target Est
21.10
Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide. It operates in three segments: Essentials, Brands, and Compounding Services. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. Its products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; and SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort. In addition, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.
www.fagron.com3,282
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: FAGR.BR
Performance Overview: FAGR.BR
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FAGR.BR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FAGR.BR
Valuation Measures
Market Cap
1.30B
Enterprise Value
1.53B
Trailing P/E
18.31
Forward P/E
15.85
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.70
Price/Book (mrq)
2.80
Enterprise Value/Revenue
2.00
Enterprise Value/EBITDA
11.38
Financial Highlights
Profitability and Income Statement
Profit Margin
9.25%
Return on Assets (ttm)
6.82%
Return on Equity (ttm)
16.18%
Revenue (ttm)
762.99M
Net Income Avi to Common (ttm)
70.55M
Diluted EPS (ttm)
0.97
Balance Sheet and Cash Flow
Total Cash (mrq)
137.28M
Total Debt/Equity (mrq)
78.60%
Levered Free Cash Flow (ttm)
63.44M
Research Analysis: FAGR.BR
Company Insights: FAGR.BR
FAGR.BR does not have Company Insights